Immunotherapy for diffuse gastric cancer: challenges and new avenues.

NPJ Precis Oncol · 2025 · PMC12280181 · PMID 40691286

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although survival benefits of nivolumab were also observed in patients with DGC, the results did not reach statistical significance, with a hazard ratio (HR) and 95% confidence interval (CI) of 0.82 (0.57–1.17) 65 .

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.